title: Current Management of Patients with Severe Aortic Regurgitation.
abstract: Chronic aortic regurgitation can result from various congenital and acquired anomalies and can be associated with proximal aortic disease. As the number of aortic valve procedures is growing, the incidence of post-procedural regurgitation also increases with associated morbidity. Typical evolution is characterized by a clinically silent phase of variable duration followed by a rather rapid decline with high incidence of adverse events. A challenge remains to find the optimal timing for an intervention: Patients are exposed to unnecessary surgical risks if treated prematurely, but peri- and post-operative prognosis is worse when the intervention is performed too late. Clinical evaluation and serial imaging tests can optimize the timing for intervention. Clinical follow-up should try to elucidate associated symptoms, with quantitative measurement of functional capacity as needed. Serial imaging examinations are required to identify sub-clinical left ventricular dysfunction or severe dilatation that should prompt a surgery. At least in selected cases, newer imaging modalities (MRI, 3D echocardiography) and/or biomarkers can help for the management of these patients, and more research is needed to determine if their systematic use can be beneficial. Medical treatment with vasodilators and anti-remodeling drugs can be helpful in some patients but should not replace or delay aortic valve surgery when indicated. Most patients will eventually be treated with surgical aortic valve replacement. Although possible in selected cases, transcatheter aortic valve replacement is not commonly used for patients with pure aortic regurgitation. For patients with prior aortic valve replacement and aortic regurgitation (paravalvular or intravalvular), emerging percutaneous approaches can be considered when available, especially for those at high surgical risk.
authors.affiliation: Institut Universitaire de Cardiologie et de Pneumologie de Québec (Quebec Heart & Lung Institute), Department of Medicine, Laval University, Québec, QC, Canada.
authors.forename: Charles
authors.initials: C
authors.lastname: Nadeau-Routhier
authors.affiliation: Institut Universitaire de Cardiologie et de Pneumologie de Québec (Quebec Heart & Lung Institute), Department of Medicine, Laval University, Québec, QC, Canada.
authors.forename: Ons
authors.initials: O
authors.lastname: Marsit
authors.affiliation: Institut Universitaire de Cardiologie et de Pneumologie de Québec (Quebec Heart & Lung Institute), Department of Medicine, Laval University, Québec, QC, Canada. jonathan.beaudoin@criucpq.ulaval.ca.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Beaudoin
keywords: Aortic regurgitation; Aortic valve replacement; Transcatheter valve replacement; Valvular heart disease